Nettet21. aug. 2024 · Longitudinal data regarding the serotype distribution and antimicrobial susceptibility of S. pneumoniae-causing invasive pneumococcal disease (IPD) in developing countries are limited. Our aim was to monitor the antimicrobial susceptibility, serotype distribution, and serotype coverage rates of the pneumococcal conjugate … NettetClinical cure rates for linezolid vs vancomycin (excluding indeterminate or missing outcomes) were 59.0% (36 of 61 patients) vs 35.5% (22 of 62 patients) for the MRSA subset ... Exclusion criteria were infecting Gram-positive organism resistant to either study medication; known or suspected meningitis, ...
Linezolid vs Vancomycin* - CHEST
Nettet13. apr. 2024 · Linezolid vs. vancomycin in MRSA pneumonia. Recent data and the IDSA guidelines suggest that linezolid is preferred over vancomycin for treating MRSA pneumonia. A systematic review and comparative meta-analysis identified seven RCTs (1239 patients) and eight retrospective case control and cohort studies (6125 patients). Nettet1. des. 2024 · Clinical cure rates at follow-up in the intent-to-treat group were higher, but not significantly different, for linezolid vs. vancomycin (78% vs. 61%; P = 0.196). clarks women\\u0027s ambyr shine pump
Vancomycin versus Linezolid in the Treatment of ... - ResearchGate
Nettet7. mar. 2024 · Daptomycin is a lipopeptide antimicrobial with activity against gram-positive organisms, including antimicrobial-resistant pathogens such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus spp [ 1,2 ]. Issues related to pharmacokinetic and pharmacodynamic considerations, challenges with … Nettet14. mai 2013 · A retrospective case-control study including 17 patients with MRSA meningitis found significantly higher microbiological cure rate at 5-day among those receiving linezolid compared to those... NettetAll isolated microorganisms were susceptible to vancomycin (minimum inhibitory concentration (MIC) = 2 mg/L) and linezolid (MIC = 1). The rate of microbiologic efficacy was 100% for patients with meningitis or ventriculitis. In the case of subdural empyema, focal infection had improved between 14 and 18 days. clarks women\\u0027s ambyr joy pump